This metabolic boost contributes to a more efficient calorie burn throughout the day, aiding in weight loss even when you're not active
Wegovy (semaglutide) and Mounjaro (tirzepatide) are part of a class of medications known as GLP-1 receptor agonists
One of the possible reasons for this is that metformin inhibits sodium-glucose cotransporter1 (SGLT1) on small intestinal epithelial cells, decreasing the intra- and extracellular Na + concentration gradient, thereby inhibiting intestinal glucose absorption and increasing glucose utilization (Lenzen et al., 1996
NCT02637284)
Likewise, peptides that may support lipolysis are not designed to offset a poor diet or a sedentary lifestyle
Weight loss varies by medical history, medication, dose, nutrition, activity, adherence, and side effects